Molecular Medicine Reports,
Год журнала:
2022,
Номер
26(5)
Опубликована: Сен. 21, 2022
Atherosclerosis
(AS)
is
a
chronic
inflammatory
disease
of
the
blood
vessels,
which
mainly
characterized
by
form
atherosclerotic
plaques
and
vascular
endothelial
injury.
Its
formation
involves
abnormal
lipid
metabolism,
oxidative
stress
inflammation,
as
well
other
processes.
AS
direct
cause
various
acute
cardiovascular
cerebrovascular
diseases,
such
myocardial
infarction
ischemic
stroke.
Early
intervention
in
process
lesion
progression
beneficial,
has
been
associated
with
primary
prevention
range
related
diseases.
Ferroptosis
non‑apoptotic
cell
death
different
from
necrosis
autophagy,
shown
to
participate
atherogenesis
through
numerous
signaling
pathways.
The
main
characteristic
ferroptosis
high
levels
cellular
iron
catalytic
free
radicals,
unsaturated
fatty
acid
accumulation
iron‑induced
reactive
oxygen
species
accumulation,
can
stress,
subsequent
DNA,
protein
damage.
There
are
hypotheses
about
pathogenesis
AS.
At
present,
it
suggested
that
accelerate
inflammation
whole
mechanisms
pathways
involvement
neuroinflammation
AS,
therapeutic
targets
have
not
yet
elucidated.
present
review
article
evaluated
perspectives
ferroptotic
death,
nervous
system
aim
exploring
new
for
Cell Death and Disease,
Год журнала:
2022,
Номер
13(2)
Опубликована: Фев. 24, 2022
Acute
kidney
injury
(AKI)
is
a
major
public
health
problem
with
high
incidence
and
mortality.
As
form
of
programmed
cell
death
(PCD),
ferroptosis
could
be
considered
as
process
iron
accumulation
enhanced
lipid
peroxidation.
Recently,
the
fundamental
roles
in
AKI
have
attracted
much
attention.
The
network
mechanism
its
to
chronic
disease
(CKD)
transition
complicated
multifactorial.
Strategies
targeting
show
great
potential.
Here,
we
review
research
progress
on
participation
AKI.
We
hope
that
this
work
will
provide
clues
for
further
studies
Oxidative Medicine and Cellular Longevity,
Год журнала:
2022,
Номер
2022, С. 1 - 21
Опубликована: Апрель 18, 2022
Atherosclerotic
vascular
disease
(ASVD)
is
the
leading
cause
of
death
worldwide.
Hyperuricemia
fourth
risk
factor
for
atherosclerosis
after
hypertension,
diabetes,
and
hyperlipidemia.
The
mechanism
hyperuricemia
affecting
occurrence
development
has
not
been
fully
elucidated.
Mononuclear
macrophages
play
critical
roles
in
all
stages
atherosclerosis.
Studies
have
confirmed
that
both
ferroptosis
promote
atherosclerosis,
but
whether
high
level
uric
acid
(HUA)
promotes
by
regulating
remains
unclear.
We
found
HUA
significantly
promoted
atherosclerotic
plaque
downregulated
protein
NRF2/SLC7A11/GPX4
signaling
pathway
ApoE-/-
mice.
Next,
we
evaluated
effect
inhibitor
ferrostatin-1
(Fer-1)
treatment
on
formation
macrophage-derived
foam
cells.
cells,
decreased
cell
viability,
increased
iron
accumulation
lipid
peroxidation
treated
with
oxidized
low-density
lipoprotein
(oxLDL);
these
effects
were
reversed
Fer-1
treatment.
Mechanistically,
inhibited
autophagy
pathway.
activated
upregulated
ferroptosis-associated
proteins.
Moreover,
an
NRF2
inducer
(tertbutyl
hydroquinone
(TBHQ))
activator
(rapamycin
(RAPA))
could
reverse
inhibitory
survival.
Our
results
suggest
HUA-induced
involved
plaques.
More
importantly,
enhancing
inhibiting
activating
may
alleviate
These
findings
might
contribute
to
a
deeper
understanding
role
pathogenesis
provide
therapeutic
target
ASVD
associated
hyperuricemia.
Medicinal Research Reviews,
Год журнала:
2023,
Номер
43(3), С. 614 - 682
Опубликована: Янв. 19, 2023
Abstract
Ferroptosis
is
an
iron‐dependent
cell
death
program
that
characterized
by
excessive
lipid
peroxidation.
Triggering
ferroptosis
has
been
proposed
as
a
promising
strategy
to
fight
cancer
and
overcome
drug
resistance
in
antitumor
therapy.
Understanding
the
molecular
interactions
structural
features
of
ferroptosis‐inducing
compounds
might
therefore
open
door
efficient
pharmacological
strategies
against
aggressive,
metastatic,
therapy‐resistant
cancer.
We
here
summarize
mechanisms
requirements
small
molecules
target
central
players
ferroptosis.
Focus
placed
on
(i)
glutathione
peroxidase
(GPX)
4,
only
GPX
isoenzyme
detoxifies
complex
membrane‐bound
hydroperoxides,
(ii)
cystine/glutamate
antiporter
system
X
c
−
for
regeneration,
(iii)
redox‐protective
transcription
factor
nuclear
erythroid
2‐related
(NRF2),
(iv)
GPX4
repression
combination
with
induced
heme
degradation
via
oxygenase‐1.
deduce
common
ferroptotic
activity
highlight
challenges
development.
Moreover,
we
critically
discuss
potential
natural
products
lead
structures
provide
comprehensive
overview
structurally
diverse
biogenic
bioinspired
trigger
iron
oxidation,
inhibition
thioredoxin/thioredoxin
reductase
or
less
defined
modes
action.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
171, С. 116112 - 116112
Опубликована: Янв. 2, 2024
Ferroptosis
is
a
newly
identified
form
of
non-apoptotic
programmed
cell
death,
characterized
by
the
iron-dependent
accumulation
lethal
lipid
reactive
oxygen
species
(ROS)
and
peroxidation
membrane
polyunsaturated
fatty
acid
phospholipids
(PUFA-PLs).
unique
among
other
death
modalities
in
many
aspects.
It
initiated
excessive
oxidative
damage
due
to
iron
overload
compromised
antioxidant
defense
systems,
including
system
Xc-/
glutathione
(GSH)/glutathione
peroxidase
4
(GPX4)
pathway
GPX4-independent
pathways.
In
past
ten
years,
ferroptosis
was
reported
play
critical
role
pathogenesis
various
cardiovascular
diseases,
e.g.,
atherosclerosis
(AS),
arrhythmia,
heart
failure,
diabetic
cardiomyopathy,
myocardial
ischemia-reperfusion
injury.
Studies
have
dysfunctional
metabolism
abnormal
expression
profiles
ferroptosis-related
factors,
iron,
GSH,
GPX4,
ferroportin
(FPN),
SLC7A11
(xCT),
as
indicators
for
atherogenesis.
Moreover,
plaque
cells,
i.e.,
vascular
endothelial
(VEC),
macrophage,
smooth
muscle
(VSMC),
positively
correlate
with
atherosclerotic
development.
Many
macromolecules,
drugs,
Chinese
herbs,
food
extracts
can
inhibit
atherogenic
process
suppressing
cells.
contrast,
some
inducers
significant
pro-atherogenic
effects.
However,
mechanisms
through
which
affects
progression
AS
still
need
be
well-known.
This
review
summarizes
molecular
their
emerging
AS,
aimed
at
providing
novel,
promising
druggable
targets
anti-AS
therapy.
Arteriosclerosis Thrombosis and Vascular Biology,
Год журнала:
2022,
Номер
42(11), С. 1283 - 1306
Опубликована: Сен. 22, 2022
During
atherosclerosis,
lipid-rich
plaques
are
formed
in
large-
and
medium-sized
arteries,
which
can
reduce
blood
flow
to
tissues.
This
situation
becomes
particularly
precarious
when
a
plaque
develops
an
unstable
phenotype
prone
rupture.
Despite
advances
identifying
treating
vulnerable
plaques,
the
mortality
rate
disability
caused
by
such
lesions
remains
number
one
health
threat
developed
countries.
Vulnerable,
characterized
large
necrotic
core,
implying
prominent
role
for
cell
death
atherosclerosis
destabilization.
Necrosis
occur
accidentally
or
be
induced
tightly
regulated
pathways.
Over
past
decades,
different
forms
of
necrosis,
including
necroptosis,
ferroptosis,
pyroptosis,
secondary
have
been
identified,
these
may
play
important
during
atherogenesis.
In
this
review,
we
describe
several
necrosis
that
how
pharmacological
modulation
pathways
stabilize
plaques.
Moreover,
some
challenges
targeting
as
presence
multiple
death-inducing
stimuli
extensive
cross-talk
between
discussed.
A
better
understanding
(regulated)
mechanisms
contributing
destabilization
open
doors
novel
strategies
will
enable
clinicians
tackle
residual
cardiovascular
risk
many
patients.
Phytotherapy Research,
Год журнала:
2023,
Номер
37(9), С. 3951 - 3963
Опубликована: Июнь 21, 2023
Abstract
Vascular
endothelial
cells
(VECs)
are
located
between
the
blood
plasma
and
vascular
tissue,
ferroptosis
(iron‐dependent
programmed
cell
death)
of
VECs
can
lead
to
a
range
cardiovascular
diseases.
Icariin
is
main
active
ingredient
Epimedium
brevicornum
Maxim.,
which
improve
dysfunction.
In
present
study,
protective
effects
icariin
on
oxidised
low‐density
lipoprotein
(ox‐LDL)‐treated
high‐fat
diet‐fed
Apolipoprotein
E‐deficient
mice
were
investigated.
Inflammatory
fibrosis
in
tissues
inflammatory
factors
serum
supernatants
detected,
mitochondrial
membrane
potential
expression
levels
ferroptosis‐associated
proteins
also
detected.
The
results
revealed
that
reduced
atherosclerotic
plaque
area
collagen
fibres
aortic
sinus
increased
viability
potential,
whereas
it
reactive
oxygen
species
VECs.
nucleation
transcription
factor
EB
(TFEB)
subsequent
autophagy
negatively
associated
with
cells,
more
prominent
autophagy,
lower
ferroptosis.
Furthermore,
by
co‐treating
two
inhibitors,
Bafilomycin
A1
(blocking
autophagosome
lysosome
fusion)
3‐methyladenine
formation),
respectively,
promoting
found
be
mediated
through
process
autophagosome–lysosome
fusion.
vivo
experiments,
ferroptosis,
alleviated
lesions
rate
TFEB
nucleation.
Additionally,
was
ARG304,
THR308
GLN311
optimal
binding
sites
for
interaction
TFEB.
Taken
together,
these
suggest
fusion
autophagosomes
lysosomes
promoted
icarrin
enhances
thus
reduces
Therefore,
may
candidate
prevention
and,
thus,
treatment
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
177, С. 117081 - 117081
Опубликована: Июль 5, 2024
The
discovery
of
an
inhibitor
for
acyl-CoA
synthetase
long-chain
family
member
4
(ACSL4),
a
protein
involved
in
the
process
cell
injury
through
ferroptosis,
has
potential
to
ameliorate
damage.
In
this
study,
we
aimed
investigate
berberine
(BBR)
as
ACSL4
order
suppress
endothelial
ferroptosis
and
provide
protection
against
atherosclerosis.
An
atherosclerosis
model
was
created
ApoE
Molecular Nutrition & Food Research,
Год журнала:
2024,
Номер
68(4)
Опубликована: Янв. 9, 2024
Scope
Age‐related
increases
in
retinal
iron
are
involved
the
development
of
degeneration.
The
recently
discovered
iron‐dependent
mechanism
cell
death
known
as
ferroptosis
has
been
linked
to
a
wide
range
pathologies.
However,
its
role
overload‐induced
degeneration
is
still
uncertain.
Puerarin
associated
with
protection.
purpose
this
research
determine
how
puerarin
prevents
under
overload
conditions.
Methods
and
results
Models
Kunming
mice,
661W
cell,
ARPE‐19
established.
Increased
deposition
significantly
worsens
pathology,
decreases
viability,
induces
ferroptotic
changes.
mitigates
by
decreasing
excessive
through
regulation
handling
proteins
lowering
lipid
peroxidation
inhibition
cyclooxygenase
2
expression
activation
nuclear
factor‐E2‐related
factor
(Nrf2)
signaling
pathway
downstream
ferroptosis‐related
(solute
carrier
family
7
member
11,
glutathione
peroxidase
4
heme
oxygenase‐1).
protective
effect
on
diminished
Nrf2‐specific
inhibitor
ML385.
Conclusion
These
findings
suggest
targeting
may
be
novel
strategy
for
management
exert
some
ocular
benefits
attenuating
ferroptosis.